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Summary 
The interleukin 3 (IL-3), I1:5, and granulocyte/macrophage colony-stimulating factor receptors 
consist of a cytokine-specific c~ subunit and the common 3  subunit. Whereas IL-3 stimulates 
various lineages of hematopoietic cells,  including muhipotential progenitors, I1:5 acts mainly 
as an eosinophil lineage-specific factor. To investigate whether the lineage specificity of II.-5 is 
due to restricted expression of the I1:5 receptor ol subunit (I1:5Rc  0, we generated transgenic 
mice that express the mouse I1:5Kc~ constitutively by phosphoglycerate kinase promoter. The 
transgenic mouse expressed I1:5P,  oc ubiquitously, and the bone marrow cells formed various 
types of colonies, including multi-lineage colonies, in response to IL-5.11,5 also supported formation 
of both multi-lineage and blast cell colonies from dormant progenitors of the 5-fluorouracil-treated 
transgenic mice. The cells composing the blast cell colony gave rise to many colonies including 
muhi-lineage colonies when they were replated in secondary culture containing either I1:5 or 
I1:3. There was no significant difference in replating efficiency or in types of secondary colonies 
between I1:5- and I1:3-stimulated cultures. Conversely, the cells from the I1:3-induced blast 
cell colonies of the transgenic mice proliferated in response to either I1:3 or IL-5.  Thus, the 
development of the progenitors can be equally supported by either I1:5 or I1:3, suggesting that 
intracellular signals from the I1:3R can be replaced by those from IL-5. These results strongly 
suggest that the lineage specificity of I1:5 is mainly due to the restricted expression of I1:SRol. 
I 
1:3, I1:5, and GM-CSF exhibit similar functions on their 
common  target  cells  such  as  eosinophils  (1-3).  These 
common functions are believed to be mediated by the shared 
receptor subunit (4-8). The high-affinity receptors for I1:3, 
I1:5,  and GM-CSF  are composed of a cytokine-specific ol 
subunit (8-10) and the common B subunit; both are members 
of the class I cytokine receptor family. The oe subunits bind 
their specific cytokine with only low affinity and form high- 
affinity receptor with the common ~  subunit (Be)  1. The ~c 
subunit by itself has no significant binding to any of these 
cytokines but is essential for high-affnity binding as well as 
signal transduction. Whereas there is only the common 
subunit in the human receptors, the mouse has an additional 
I1:3-specific B subunit (/~rL3, also known as AIC2A) that is 
91%  identical to the mouse ~/c (also known as AIC2B)  at 
1 Abbreviations used in this paper: 8r  common 3 subunit; 31L3, IL-3-specific 
B subunit; BMC, bone marrow cell; Epo, erythropoietin; FU, fluorouracil; 
IL-3Ro~, IL-3Rc~ subunit; PGK-1, phosphoglycerate kinase 1. 
the amino acid level (11). The two/~ subunits are coexpressed 
on various hematopoietic cells.  Interestingly, however,/3IL3 
itself binds mouse I1:3 with low affnity and interacts with 
only I1:3Ro~ subunit (I1:3Ro  0  (10).  The physiological role 
of ~IL3 in the mouse remains unknown. 
Whereas I1:3, II:5, and GM-CSF exhibit similar functions 
on target cells such as eosinophils, they also have their in- 
dividual functions. I1:3 stimulates hematopoietic stem cells 
as well as various lineage-committed progenitors including 
granulocytes, macrophages, eosinophils, mast cells, megakaryo- 
cytes,  and  erythroid  cells  (12),  so  I1:3  is  also  known  as 
multi-CSE GM-CSF was originally defined as a factor that 
stimulates colony formation of granulocytes and macrophages. 
Subsequent studies, however, have shown that GM-CSF in- 
teracts with a much broader range of cells including uncom- 
mitted multipotential progenitors (13). In contrast, I1:5, orig- 
inally found as a B cell differentiation factor that stimulates 
production of IgM and IgA in mouse (14,  15), has a major 
role in eosinophil development in both mouse and human, 
and primitive hematopoietic progenitors do not respond to 
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solid cultures of mouse normal bone marrow cells (BMC) 
or spleen cells. 
These functional differences may be due to different means 
of signal transduction among the three ot subunits. Alterna- 
tively, because the three ot subunits are equivalent in signaling, 
the differential response to cytokines may be due to differen- 
tial expression of the o~ subunits. We have approached this 
question by generating transgenic mice expressing the Ib 
5gc~ ubiquitously. BMC from the IbSP, ot transgenic mouse 
formed colonies of multiple lineages in response to Ib5, in- 
dicating that Ib5ot has a potential similar to IL-3Rot when 
it is expressed on early progenitors. Thus, the lineage-restricted 
response of BMC to II.-5 is most likely due to the restricted 
expression of II.-5Rot on eosinophils. 
Materials  and Methods 
Construction of the Phosphoglycerate Kinase 1-IL5Rce Gene and 
Pwduction of Transs  Mice.  An XhoI fragment carrying mouse 
IL-5Rot eDNA in plb5R.8 plasmid (9) was placed between the 
phosphoglycerate kinase (PGK) 1 promoter (17) and the SV40 early 
polyadenylation signal (Fig. 1). The plasmid vector for the PGK-1 
promoter was provided by R. Murray (DNAX). A purified BamHI 
fragment containing PGK-Ib5Rot was microinjected into pronuclei 
of fertilized eggs of C57BL/6  x  SJL F2 hybrid mice as described 
(18) by DNX, Inc. (Princeton,  NJ). Transgenic mice were screened 
by PCR and Southern blot analysis of tail DNA using an entire 
Ib5Rc~ eDNA fragment as a probe, as described previously (19). 
PCR. reaction  was performed by using AmpliTaq DNA poly- 
merase (Perkin Elmer-Cetus,  Norwalk, CT), 20 pmol of primers, 
and 1 gg tail DNA for 30 cycles (94~  1 rain, 52~  2 min, 720C 
3 rain), followed by 10 min at 72~  Oligonucleotide primers, P1 
and P2, are shown in Fig. 1. The 5' primer (Pl: 5'ACGCTTCAA- 
AAGCGCACGTCTY) was in the PGK-1 promoter gene, and the 
3' primer (P2: 5'AACTTGAGCTAATCCAG~Y)  was in the 
Ib5Rc~ gene. PCR products were electrophoresed on 1.5% agarose 
gels and stained with ethidium bromide. The expected size of the 
PCR product was 541 bp, and the identity of the PCR product 
was confirmed by digestion with either HindlII or Xhol. 
RT-PCR.  Total RNAs were isolated from various tissues and 
cells using the acid-guanidinium-phenol-chloroform protocol (20) 
(Clontech Laboratories, Palo Alto, CA). Polyinosinic acid (10 gg) 
was added as a carrier when RNA was extracted from blast cell 
colonies. In all cases, RNA preparations were subjected to a DNase I 
(GenHunter, Brookline, MA) digestion step before eDNA synthesis, 
thus eliminating any remaining genomic DNA. Total RNA was 
reverse transcribed using a First-Strand eDNA Synthesis Kit (Phar- 
macia, Piscataway, NJ) for 1 h at 37~  PCR was performed by 
using Pl and P2 primers under the same conditions as described 
above. To check for genomic DNA contamination, a control reac- 
tion with heat-inactivated reverse transcriptase was always included. 
Flow CTtoraetry.  BMC from transgenic mice and their normal 
littermates  were prepared  after removing red blood cells using 
ammonium chloride buffer solution. A mydoid call line, OTT1 
(21), was maintained in RPMI medium containing 10% FCS (Sigma 
Chemical Co., St Louis, MO), 50 gM 2-ME (Sigma Chemical Co.) 
and 10 ng/ml mouse I1--3. Cells (106) in 50 gl of PBS containing 
5% FCS were incubated with 1/zg of  purified mAb, H7 (rat IgG2a), 
which recognizes  Ib-5Rot (22),  or rat IgG2a (Pharmingen, San 
Diego, CA) as an isotype control for 30 min at 4~  Cells were 
pelleted,  washed with PBS, and incubated with PE-conjugated 
goat anti-rat IgG (H+L) (Boehringer  Mannheim, Indianapolis, 
IN) for 30 rain at 4~  These cells were washed, resuspended in 
1 ml PBS, and analyzed on a FACScan  |  (Becton Dickinson & Co., 
San Jose,  CA). 
CellPreparation.  Single-cell  suspensions were prepared from bone 
marrow or spleen of 6-8-wk-old mice. BMC were flushed from 
femurs and tibiae into a-medium (GIBCO BRL, Gaithersburg, 
ME)) by using a 26-gauge  needle. Spleen cells were prepared by 
teasing the spleen in 3 ml of c~-medium in a 35-mm suspension 
culture dish (model  171099; Nunc, Inc., Naperville,  IL) and by 
repeated pipetting. Either BMC or spleen cells were passed through 
a 70-#m nylon cell strainer (model 2350; Becton Dickinson Lab- 
ware, Franklin Lakes, NJ). 
5-fluorouracil  (FU)  (Sigma  Chemical Co.)  was  administered 
through tail veins of mice at a dosage of 150 mg/kg body weight 
(23). Spleen cells and BMC were harvested 4 d and 2 d after the 
5-FU injection, respectively. 
Growth Factors.  Recombinant mouse II.-3 and GM-CSF were 
produced in silkworm and yeast, respectively (24, 25). Recombinant 
mouse IL-5, human I1.-6, and human erythropoietin (Epo) were 
purchased from R&D Systems, Inc., (Minneapolis, MN). Unless 
otherwise specified, concentrations of growth factors used in this 
study were as follows: II.-3, 10 ng/ml; II.-5, 100 ng/ml; GM-CSF, 
10 ng/ml; Ib6,  100 ng/ml; Epo, 2 U/ml. 
Clonal Cell Cultures.  Methylcellulose culture was carried out 
in 35-mm suspension culture dishes (model 171099, Nunc, Inc.). 
1-ml of culture mixture consisted of 2  x  104 BMC from 5-FU- 
untreated mice, 5  x  104 BMC from 5-FU-treated mice, or 1  x 
106 spleen cells from 5-FU-treated mice; o~-medium; 0.9% 4000 
centipoises methylcellulose (Fisher, Norcross, GA); 30% FCS (Hy- 
clone Laboratories, Logan, UT);  1% deionized,  fraction  V BSA 
(Sigma Chemical Co.); 100 ~tM 2-ME; and hematopoietic growth 
factors. In a serum-flee culture, FCS was replaced with a combina- 
tion of 1%  deionized  crystallized  BSA (Sigma Chemical Co.), 
300 gg/ml  30%  iron-saturated  human  transferrin  (Boehringer 
Mannheim),  160 #g/ml soybean lecithin, 96 #g/ml cholesterol and 
100 nM sodium selenite (all from Sigma Chemical Co.);  fraction 
V BSA was omitted. Dishes were incubated at 37~  in a humidified 
atmosphere with 5% CO2 in air. Colony types were determined 
on day 16 of incubation by in situ observation on an inverted mi- 
croscope according  to the criteria described previously (26). Ex- 
cept for megakaryocyte colonies, colonies consisting of/>50 cells 
were scored. Abbreviations  of colony types are as follows: GM, 
granulocyte/macrophage colonies; M~, macrophage colonies; Eo, 
eosinophil colonies; GMM, granulocyte/macrophage/megakaryo- 
cyte colonies; GEM, granulocyte/erythrocyte/macrophage  colonies; 
GEMM, granulocyte/erythrocyte/macrophage/megakaryocyte colo- 
nies; EM, erythrocyte/megakaryocyte  colonies; Meg, megakaryo- 
cyte colonies; BFU-E, erythroid bursts; and Mast, mast cell colonies. 
Replating Experiments.  To determine the potential of the blast 
cell colonies, we carried out replating experiments  of individual 
blast cell colonies developed in cultures of spleen cells from 5-FU- 
treated  normal or transgenic  mice. Individual  blast cell colonies 
developed on day 7 of incubation in the presence of Ib5 or Ib3 
were picked up with a micropipette  (Eppendorf North America, 
Inc.,  Madison,  WI) on  an inverted microscope,  resuspended  in 
100/zl of or-medium, gently pipetted, and divided into three parts. 
Each aliquot of the ceU suspension was added to secondary culture 
medium containing Ib3 plus Epo, IL-5 plus Epo, or Epo alone. 
Replated cells were cultured and secondary colonies were scored 
in the same manner as primary cultures. 
890  II:5Kot Subunit Transgenic Mouse Results 
Production of Mouse IL5R~  Transgen~ Mice.  To express 
IL-5Rot in immature hematopoietic progenitor cells constit- 
utively, we used the PGK promoter since PGK is a house- 
keeping enzyme that is expressed at a high level  in virtually 
all cell types (27) and the PGK-1 promoter is highly active 
in embryonic tissues, especially  in mouse embryonic stem (ES) 
cells (28). To generate transgenic mice, a 2.6-kb DNA frag- 
ment containing mouse PGK-1 promoter, mouse II.-5Ro~ 
cDNA, and SV40 early poly A tail (Fig.l) was microinjected 
into C57BL/6  x  SJL F2 hybrid mouse eggs. For screening 
transgenic mice, tail DNA was analyzed by PCR with oli- 
gonucleotide primers, Pl and P2 (Fig.l).  Integration of the 
transgene was then confirmed  by Southern blot analysis  with 
entire mouse II~5Rol cDNA as a probe (data not shown). 
Four founder mice were found to carry the mouse IL-5Rol 
transgene (Nos.  5, 12, 13, and 18) among 20 offspring. By 
crossing to C57BL/6 mice, two (Nos.  5 and 13) of them 
transmitted the transgene to half of their offspring, regard- 
less of their sex. 
Expression of mouse IL-5Rcr Gene in Transgenic  Mice.  RT- 
PCR analysis was performed to examine expression of the 
transgene.  To ensure that the PCR products  were actually 
derived from RNA, the extracts from various tissues were 
treated with DNase I before reverse transcriptase reaction. 
PCR was performed for 30 cycles. Control PCR using heat- 
inactivated reverse transcriptase was also performed to check 
genomic DNA contamination. We used the same primers 
as those for the tail DNA screening, which covered both 
PGK-1 promoter and II~5Ra cDNA. No PCR product was 
obtained in normal littermate mice (data not shown). The 
IL-5Rc~ transgene was expressed ubiquitously in transgenic 
mice derived from the No.  13 mouse (Fig. 2).  Expression 
of  the IL-SRot transgene in BMC was also confirmed by using 
a mAb, H7 (22). Approximately 20% of the BMC of trans- 
genic mice from No.  13 were stained with H7 (Fig. 3). In 
contrast, IL-5Rol expression was hardly detected in transgenic 
PGK-1 
promoter 
Primer 1 
466b  475b 
￿9  -> 
Mouse IL-5Ra  SV early polyA 
cDNA 
BamHI  Xhol  Hindlll  Primer2  Xhol  Banfrll 
557b  807b  1016b  2383b  2645b 
Figure  1.  Structure of I1,5R~ transgene. The mouse PGK-1 promoter 
and the poly A addition site of the SV40 early gene were placed upstream 
and downstream of the mouse IL-5Rcr cDNA, respectively, as described 
in Materials and Methods.  The BamHI fragment was injected into fertil- 
ized eggs of C57BL/6  x  SJL F2 hybrid mice. (V) The putative transcrip- 
tion start site. To distinguish  the transgene product  from the endogenous 
gene product, PCR primers  1 and 2 were chosen to cover both PGK-1 
promoter and  IL-5Rc~ sequences. 
Figure  2.  RT-PCR analysis of transgene expression. RNA was prepared 
from various tissues of I1,5R.a transgenic mice (No. 13 founder  mouse). 
cDNA derived from 1/zg total KNA was used for PCR. PCR was per- 
formed for 30 cycles. Lane (-) is the PCR product with heat-inactivated 
reverse trancriptase in cDNA synthesis reaction. The PCR product without 
cDNA is also shown as H20.  First lane is a DNA size marker  (Hinfl- 
digested  c~X174). Expression  of the I1,5Rc~ transgene  was observed in 
bone marrow,  spleen,  thymus,  liver, kidney,  and brain. 
mice from No. 5 by RT-PCR and FACS  |  analysis (data not 
shown). We therefore analyzed hemizygote transgenic mice 
from the No. 13 female  mouse in this study. In all experiments, 
we used as negative controls normal littermates whose genetic 
backgrounds were identical to those of the transgenic mice. 
Both blood cell count and blood picture of the transgenic 
mice were normal. Neither eosinophilia nor lymphocytosis 
was observed in the transgenic  mice. 
Dose-dependent  Effect ofll_,5.  BMC of  the transgenic mouse 
formed colonies in an IbS-dependent manner (Fig. 4). I1-5 
stimulated only a few eosinophil  colonies  from BMC of  normal 
mice. In contrast,  various types of colonies were formed in 
response to IF5 from the IL-5Rot transgenic mice. The number 
of colonies reached the maximal level at 100 ng/ml IL-5. At 
this concentration, the total number of colonies was com- 
parable with that of  colonies supported by the optimum con- 
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Figure  3.  Cell surface expression of IL-5Rcr  BMC of IL-5Ra trans- 
genic mice derived from No. 13 mouse or their normal littermates  were 
incubated with H7 and stained with PE-conjugated  anti-rat  IgG (H + L). 
Fluorescence was analyzed by FACScan  |  OTT1 cells, a mouse myeloid 
cell line which responds to IL-3, GM-CSF, and II,5 (22), were also stained 
with H7 as a positive  control. 
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Figure  4.  Ib5-dependent colony formation. Total number of colonies 
formed from 2  x  104 BMC of 11:5R~ transgenic mice or normal litter- 
mates were scored. 
centration of Ib3. Thus, we employed 100 ng/ml II.-5 to ana- 
lyze the effect of I1.,5 more precisely on the hematopoietic 
progenitor cells of Ib51Lot transgenic mice in subsequent 
studies. 
IL.5-dependent  Hematopoietic Colony Formation.  The 
number of GM and macrophage colonies supported by GM- 
CSF was almost the same between the transgenic mice and 
the normal littermates, ensuring that an equal number of pro- 
genitor cells was plated in a dish in this experiment (Fig. 
5 A). As reported previously (12, 16), II.-5 supported the 
growth of a small number of eosinophil colonies from BMC 
of normal mice, whereas various types of colonies developed 
in the presence of II.-3. In contrast, both Ib5 and IL-3 equally 
stimulated development of GM, M<k GMM, Meg, and Mast 
colonies from BMC of transgenic mice (Fig. 5 B). Several 
eosinophil colonies were also formed in the culture of BMC 
of the transgenic mice in the presence of IL-5. Numbers and 
size did not exceed the eosinophil colonies derived from normal 
mice upon II.-5 stimulation. We could not find any erythroid 
lineage colonies in the culture of BMC of transgenic mice 
stimulated with IL-5 alone, indicating the inability of IL-5 
A 
B 
Transgenic mouse 
NO. of colonies / 2x104 BM cells 
100  90  80  70  30  20  10 
￿9  GM-CSF 
GM 
M~ 
Eo 
Normal littermate 
No, of colonies / 2x104 BM ceils 
0  10  20  30  70  80  90  100 
￿9  GM-CSF 
110  100  90  80  40  30  20  10  0 
....  ~t!  ............  ,  ...........  !  ............  !  ............... 
IL-3 
m  IL-5  4 
r-~  NO Factor 
M#  I~, 
GMM 
Meg 
Mast 
0  10  20  30  40  80  90  100  110 
I  ,  ,).  .... 
IL-3 
l  IL-5 
r~  No Factor 
C  110  100  90  80  70  30  20  10 
IL-3 + Epo 
,/i 
i  IL-5 + Epo 
I 
rn  Epo  i~ 
GM 
M# 
Eo 
GMM 
GEM 
GEMM 
EM 
Meg 
BFU-E 
Mast 
10  20  30  70  80  90  100  110 
::::::::::::::::::::::::::::::::::::::  I 
r~  IL-3+ Epo 
al  IL-5 + Epo 
rn  Epo 
Figure  5.  IL-5-induced colony  formation.  BMC 
(2  ￿  10  4 cells)  from  IL-5Rc~ transgenic  mice  or 
normal littermates were plated in the presence of FCS 
and various cytokines as indicated. The results are mean 
+  SD  from  triplicate  cultures.  Concentrations  of 
growth factors are as follows: 1I:3,  10 ng/ml; 11:5, 
100 ng/ml; GM-CSF,  10 ng/ml; and Epo, 2 U/ml. 
892  I1:5R~  Subunit Transgenic Mouse Figure 6.  Morphology  of a GEMM colony. (Left) A portion of a typical  large GEMM colony  from BMC of IL-51L(x  transgenic  mice on day 16 
of  incubation  in the presence  of  IL-5 and Epo. xl00. (Right)  A portion  of  a Wright Giemsa-stained  smear  of  the colony  shown  at left, revealing  immature 
myeloid cells, mast cells, erythroblasts, and megakaryocytes, x400. 
to substitute for Epo.  In the presence of Epo,  IL-5 as well 
as IL-3 supported the formation of BFU-E and multi-lineage 
colonies containing erythroid cells such as GEM,  GEMM, 
and EM colonies (Fig.  5 C  and Fig. 6). We also examined 
IL-5-induced colony formation from BMC of the transgenic 
mouse in serum-free condition, because FCS may contain var- 
ious types of hematopoietic growth factors (29-32).  Again, 
the effects of IL-3 on hematopoietic colony formation were 
completely replaced by IL-5 in the serum-free culture of BMC 
of the transgenic mice (Fig.  7). 
Colony Formation  from BMC of 5-FU-treated Mice.  To in- 
vestigate the effects of Ib5 on the development of primitive 
hematopoietic progenitors, we used BMC of 5-FU-treated 
mice. It is well established that the cell cycle of dormant pro- 
genitor cells is regulated by early acting cytokines such as 
IL-6, G-CSF, IL-11, leukemia inhibitory factor, I1:12, and stem 
cell factor (33).  IL-3 is known to support the proliferation 
of multi-lineage progenitors when they exit from Go (12), 
and IL-3 supported formation of a few multi-lineage colonies 
from 5-FU-treated BMC of  both normal and transgenic mice 
(Fig.  8). As reported previously (34, 35), a combination of 
IL-3 and IL-6 enhanced the formation of many multi-lineage 
colonies. Although IL-5 failed to support any colony forma- 
tion from 5-FU-treated BMC of normal mice, a small number 
of multi-lineage colonies developed from 5-FU-treated BMC 
of transgenic mice in the presence of I1:5. I1:6 markedly syn- 
ergized with 11:5 as well as IL-3 in support of multi-lineage 
colony formation from 5-FU-treated BMC of transgenic mice. 
These results indicate that the ability of II:5 to support an 
early stage of hematopoietic development is comparable with 
that  of IL-3 in  transgenic mice. 
Replating Experiment of Blast Cell Colonies.  From spleen 
cells of 5-FU-treated mice, I1:3 supports formation of mul- 
tipotential blast cell colonies which are highly enriched for 
progenitors (12, 36). When spleen cells from the transgenic 
mice treated with  5-FU  were cultured in  methylcellulose 
medium containing I1:3  or IL-5, small colonies consisting 
of blast cells with little sign of differentiation developed on 
day 7 of culture. In both cultures, approximately five blast 
cell colonies consisting of 50-200 blast cells were identified 
in a dish with 106 spleen cells. Expression of IL-SRc~ trans- 
gene in these blast cell colonies was confirmed by use of RT- 
PCR  (Fig.  9).  Individual blast cell colonies were lifted on 
day 7, suspended in o~ medium, and divided into three parts. 
Each aliquot of the cell suspension was added to secondary 
culture medium containing IL-3 plus Epo,  IL-5 plus Epo, or 
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Figure  7.  Colony formation from BMC of IL- 
5Ka  trnasgenic  mice or  normal  littermates  in 
serum-free cultures.  The results are mean  +_  SD 
from triplicate cultures.  See legend to Fig. 5 for 
concentrations  of growth factors. 
Epo alone.  Blast cell colonies supported by Ib5  responded 
not only to II.-5 but also to Ib3 and gave rise to secondary 
colonies  (Table  1).  Conversely,  Ib3-induced  blast  cells 
responded to either II~3 or IIr  As previously reported (12, 
36), very heterogeneous distribution of secondary colonies, 
including the incidence of GEMM colonies, was observed. 
On the other hand, the blast cells showed similar replating 
efficiency and similar distribution of secondary colony types 
when they were divided and individually replated in the sec- 
ondary culture containing either II.-3 or II~5. There was no 
significant difference in the fate of the blast cells regardless 
of whether Ib3  or Ib5 was used as a second stimulus. 
In contrast to the transgenic mice, blast cell colonies were 
developed in the culture of spleen cells of the 5-FU-treated 
normal mice in the presence of IL-3, but not in the culture 
with Ib5. Normal mice-derived blast cell colonies supported 
by Ib3 gave rise to very few or no secondary colonies upon 
stimulation with IL-5, whereas II:3 supported many secondary 
colonies including muhi-lineage colonies from the same blast 
cells (Table 2). 
These results indicate that 5-FU-resistant dormant hema- 
topoietic progenitors of transgenic mice actually express both 
IL-3 and IL-5 receptors on their surface and that development 
of the progenitors can be equally supported by either Ib3 
or IL-5. Results of replating studies also show that Ib5-in- 
duced formation of multi-lineage colonies results from di- 
rect action of IL-5 on progenitor cells, but not through ac- 
cessory cells such as macrophages and lymphocytes, because 
blast cell colonies are devoid of any accessory cells or stromal 
cells. 
Discussion 
Whereas IL-3, GM-CSF, and Ib5 exhibit some similar func- 
tions on eosinophils and basophils  (37,  38),  there are also 
remarkable functional differences among them. In particular, 
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Figure 8.  Colony formation from day 2 post-5-FU 
BMC of IL-5Rot transgenic mice or normal littermates. 
The results are mean  _+  SD from triplicate cultures. 
See legend  to Fig.  5 for concentrations  of growth 
factors. 100 ng/ml IL-6 was used in this experiment. Figure  9.  Expression of IL-5Rot 
mRNA  in  Ib5-induced blast cell 
colonies. Spleen cells from 5-FU- 
treated IL-5Rc~  transgenic mice were 
incubated with IL-3  or I1.,5  in the ab- 
sence  of  Epo. On day 7 of  incubation, 
50 blast cell colonies consisting of 
100-200 cells were pooled, washed 
with PBS, and lysed  in denaturing so- 
lutions with 10 #g polyinosinic  acid 
as an RNA carrier."  Using RNA from 
one quadrant of the lysate, cDNA  was 
synthesized. PCR was performed  for 
35 cycles.  Lane (-) is the PCR prod- 
uct with heat-inactivated  reverse  tran- 
scriptase in the cDNA synthesis  reac- 
tion. The PCR product without any 
cDNA is also shown as H20. First 
lane is a DNA size marker (Hinfl- 
digested ~X174 ). 
some functions of IL-3 and II.-5 are quite different. We have 
previously  demonstrated  that  the  functional  high-affinity 
receptors for IL-3, IL-5, and GM-CSF are composed of or and 
3  subunits (39).  The ot subunits are cytokine specific,  each 
cytokine having its own specific  ot subunit.  There are two 
distinct fl subunits in the mouse; tic is shared by these three 
receptors, whereas flIL3 is specific to the IL-3 receptor. Thus, 
the marked difference of the biological activities between IL-3 
and II75 may be due to cellular signaling differences between 
cytokine-specific o~ subunits or between flIL3 and tic.  Alter- 
natively, the difference may simply reflect the different pat- 
tern  of expression of the  ot subunits. 
These  possibilities  may  be  distinguished  by  analyzing 
receptor expression. Whereas a wide distribution of IL-3Rc~ 
in hematopoietic cells  has been reported  (10),  anti-IL-SRot 
antibody did not show significant staining of BMC (40) (Fig. 
3). However, expression studies may not provide conclusive 
evidence to discriminate between the two possibilities, as the 
receptor expression can be measured only to a certain limit 
of sensitivity.  Instead of studying receptor expression directly, 
we have approached the question by generating a transgenic 
mouse expressing the IL-5Rot constitutively.  We have used 
the PGK promoter to express IL-5Rot, as PGK is a house- 
keeping enzyme that  is present in various tissues constitu- 
tively.  In fact, we detected IL-5Rot in various tissues of the 
transgenic  mouse,  where at  least 20%  of total BMC were 
stained with the anti-Ib5Rot antibody. IL-5Rcr was expressed 
in blast cells from transgenic mice, which have the potential 
to differentiate  to various  lineages. 
By using  the BMC  of transgenic  mice,  we have  shown 
that  IL-5 is able to support development of multi-potential 
progenitor cells without induction of preferential differenti- 
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ation toward the eosinophil lineage in the Ib5Rot transgenic 
mouse. IL-5 supported formation of various types of colonies 
in methylcellulose culture of BMC from the IL-5Rot trans- 
genic mice. These colonies included not only eosinophil colo- 
nies, but also GM, macrophage, GMM, Meg, and Mast colo- 
nies. There was no difference in number or size of IL-5-induced 
eosinophil colonies between the normal and the transgenic 
mice. Ib5 induced the colony formation of blast cells with 
no signs of terminal differentiation from 5-FU-treated spleen 
cells  of the  transgenic  mice on  day 7  of incubation.  Our 
replating studies of individual  blast cell colonies clearly demon- 
strated that proliferation of CFU blasts of the IL-5Rot trans- 
genic  mouse and  their  differentiation  to  terminal  cells  are 
equally supported by either IL-5 or IL-3, and that switching 
the cytokine from Ib5 to IL-3, or from Ib3 to Ib5 does not 
affect the  differentiation  of blast cells. 
These results indicate  that  intracellular  signals from the 
IL-3 receptors can be replaced with those from the Ib5 receptor 
and that the restricted response of the normal mouse BMC 
to IL-5 is likely due to the restricted expression of Ib5Rc~. 
Thus,  the  progenitors  do  not  appear  to  require  IL-3Rot 
chain-specific or fliL3-Specific signals  for their hematopoietic 
development, and tic together with IL-SRot is able to trans- 
duce essential signals  for the development of multi-lineage 
hematopoietic progenitors.  However, our results do not ex- 
clude  the possibility that  each  ot  subunit  and  filL3 plays  a 
specific role in hematopoietic development, which may not 
be obvious by the in vitro colony assays employed in this study. 
To further investigate the role of filL3 or /3~ in the develop- 
ment of hematopoietic cells, knockout mice that lack either 
of the  two fl genes will be useful. 
Recently, Dubart  et al.  (41) introduced  the normal  Epo 
receptor (EpoR) cDNA into mouse BMC using a retrovirus 
vector and analyzed growth of pluripotent progenitors upon 
Epo stimulation. Epo is a lineage-specific cytokine whose func- 
tion is usually limited only to the proliferation and differen- 
tiation of late erythroid progenitors.  They observed that the 
EpoR-infected BMC responded to Epo alone and gave rise 
to mixed colonies including erythrocytes, granulocytes, mac- 
rophages, and megakaryocytes. The mixed colonies contained 
the cells with a potential to form secondary colonies. These 
results indicate that EpoR is capable of stimulating the multi- 
potential progenitors without restricting their differentiation 
potential to only an erythroid lineage.  These results are con- 
sistent with our results using the IL-SRot transgenic mouse 
and are also consistent with the results that EpoR and IL-3/ 
IL-5/GM-CSF receptors share many common signaling path- 
ways (42,  43). 
However, there is a significant difference between EpoR- 
infected BMC and the IL-SRot transgenic mouse. Epo alone 
supported  erythrocyte  development  in  the  EpoR-infected 
BMC, whereas IL-3 or Ib5 alone did not support erythro- 
cyte development. Whereas IL-5Rot is expressed constitutively 
in the transgenic mouse, II:5 response absolutely depends on 
the presence of tic.  Thus,  the difference may be due to the 
lack of B~ at a late stage of erythrocyte differentiation.  Al- 
ternatively,  there may be a difference in signaling pathways 
between EpoR and Ib3/IL-5/GM-CSF receptors.  The mouse O
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 Table 2.  Reflating  Studies of Normal Mouse Blast Cell Colonies 
Stimuli  No. of secondary colonies 
Blast cell  Replating 
colony  Size  Primary  Secondary  GM  GEM  GMM  GEMM  Mast  Total  efficiency 
% 
IL-3 + Epo  21  0  0  4  0  25  105.6 
1  71  IL-3  IL-5 + Epo  1  0  0  0  0  1  4.2 
Epo  0  0  0  0  0  0  0 
IL-3 + Epo  8  0  0  10  0  18  62.1 
2  87  IL-3  IL-5 + Epo  0  0  0  0  0  0  0 
Epo  0  0  0  0  0  0  0 
IL-3 + Epo  31  0  0  1  0  32  87.3 
3  110  IL-3  IL-5 + Epo  0  0  0  0  0  0  0 
Epo  0  0  0  0  0  0  0 
IL-3 + Epo  8  0  0  2  0  10  19.7 
4  152  IL-3  IL-5 + Epo  0  0  0  0  0  0  0 
Epo  0  0  0  0  0  0  0 
IL-3 + Epo  18  0  0  2  0  20  54.3 
5  189  IL-3  IL-5 + Epo  0  0  0  0  0  0  0 
Epo  0  0  0  0  0  0  0 
IL-3 + Epo  36  0  0  2  0  38  57.0 
6  200  IL-3  IL-5 + Epo  0  0  0  0  0  0  0 
Epo  0  0  0  0  0  0  0 
Spleen cells from normal littermates. Please see Table 1 for details. Note that IL-5 could not support blast cell colony  formation  from spleen cells 
of normal littermates. 
Ib3-dependent BaF3 transfected with the EpoR proliferated 
in response to either I1:3 or Epo, whereas only Epo induced 
globin synthesis (44, 45), indicating a difference in signaling 
pathways. Therefore it is possible that Epo-specific signaling 
is  required  for a  late stage of erythrocyte differentiation. 
Whereas it is not clear from the report by Dubart et al. (41) 
whether Epo can support eosinophil differentiation in the 
EpoR-infected BMC, terminal differentiation of eosinophils 
may also require I1:5-specific  signaling. These observations 
collectively suggest the possibility that cytokines such as 
I1:3/I1:5/GM-CSF or Epo induce proliferation signals in early 
hematopoietic progenitors expressing their receptors but may 
not instruct the direction of differentiation. Cytokine-specific 
signals may be required after commitment to a particular lin- 
eage such as erythrocytes or eosinophils. 
It is well established that II:3 and I1:6 synergistically stimu- 
late formation of multi-lineage colonies (34,  35).  Whereas 
I1:5 alone supported formation of a few multi-lineage colo- 
nies from BMC of the 5-FU-treated transgenic mice, a marked 
synergy between I1:5 and Ib6 was observed.  As the multi- 
potential progenitors appear to express 1b5Ro~ constitutively, 
synergy by 11:6 is probably not due to upregulation of the 
ol subunit. Recently, McClanahan et al. (46) analyzed pat- 
terns of expression of various cytokine receptor genes in de- 
veloping embryoid bodies from ES cells. They demonstrated 
that genes for Ib3Rc~ and GM-CSFRc~ are expressed con- 
stitutively in ES cells, as well as across the entire time course 
of embryoid body development. In contrast, ~o and 31r3 are 
upregnlated in day 7 embryoid bodies.  Thus, it is possible 
that I1,6 stimulates the transition of hematopoietic progen- 
itors from the dormant Go stage to a cycling stage and that 
this  transition is  accompanied by upregnlation  of the 
subunits. The marked synergy between I1:5 and Ib6 may 
result from enhanced formation of high-af~nity receptors by 
association of II.-5Ro~ to the upregulated 3  subunits on the 
progenitors. BMC from transgenic mouse expressing not only 
an c~ subunit but a ~  subunit may provide a unique system 
for analyzing these questions. 
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